Products
Online Inquiry
TT-OAD2
Inquiry
Cat. No.:
OB0425LY-096
Synonyms:
2382719-60-8; (S)-2-((3S,8S)-3-(4-((3,4-Dichlorobenzyl)oxy)phenyl)-7-((S)-1-phenylpropyl)-2,3,6,7,8,9-hexahydro-[1,4]dioxino[2,3-g]isoquinoline-8-carboxamido)-3-(4-(2,3-dimethylpyridin-4-yl)phenyl)propanoic acid dihydrochloride; (2S)-2-[[(3S,8S)-3-[4-[(3,4-Dichlorophenyl)methoxy]phenyl]-7-[(1S)-1-phenylpropyl]-3,6,8,9-tetrahydro-2H-[1,4]dioxino[2,3-g]isoquinoline-8-carbonyl]amino]-3-[4-(2,3-dimethylpyridin-4-yl)phenyl]propanoic acid;dihydrochloride
Size:
1 mg; 5 mg; 10 mg; 50 mg; 100 mg
CAS No.:
2382719-60-8
Compound CID:
146026066
Specification
Description:
TT-OAD2 is a synthesized form of TT-OAD2 free base with potential biological activity.
Formula Weight:
929.75
Applications:
TT-OAD2 can be used for metabolic disease research and drug screening.
Storage:
Storage at 4°C.
Formula:
C50H49Cl4N3O6
Appearance:
Solid
Purity:
99.77%, determined by HPLC.
Solubility:
DMSO
Pathway:
GPCR/G protein
Identity:
Confirmed by NMR and LC-MS.
Target:
GCGR
Library Information
Solubility:
DMSO